Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Cardiol Therapeutics Inc.

    NASDAQ: CRDL · Real-Time Price · USD
    1.42
    -0.04 (-2.74%)
    At close: Jun 16, 2025, 3:59 PM
    1.43
    0.70%
    After-hours: Jun 16, 2025, 07:09 PM EDT
    -2.74%
    Bid 1.39
    Market Cap 117.36M
    Revenue (ttm) n/a
    Net Income (ttm) -36.68M
    EPS (ttm) -0.35
    PE Ratio (ttm) -4.06
    Forward PE -3.04
    Analyst Buy
    Ask 1.5
    Volume 97,329
    Avg. Volume (20D) 197,457
    Open 1.46
    Previous Close 1.46
    Day's Range 1.42 - 1.49
    52-Week Range 0.77 - 2.63
    Beta 0.76

    About CRDL

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol CRDL
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for CRDL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    8 months ago
    -6.63%
    Cardiol Therapeutics shares are trading lower afte... Unlock content with Pro Subscription
    8 months ago
    +3.7%
    Cardiol Therapeutics shares are trading lower after the company announced a preliminary prospectus for a proposed public offering of common stock, size or amount not disclosed.
    news image

    2 weeks ago · newsfilecorp.com

    Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders

    Toronto, Ontario--(Newsfile Corp. - May 29, 2025) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on developing anti...

    news image

    3 weeks ago · newsfilecorp.com

    Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on May 28th at 4:30 p.m. EDT

    Toronto, Ontario--(Newsfile Corp. - May 27, 2025) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on developing anti...

    news image

    1 month ago · newsfilecorp.com

    Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors

    Former Chief Medical Officer of Eli Lilly brings more than thirty years of pharmaceutical industry experience Toronto, Ontario--(Newsfile Corp. - April 29, 2025) - Cardiol Therapeutics Inc. (NASDAQ: C...

    news image

    1 month ago · zacks.com

    Cardiol Therapeutics Stock: Is Cannabis Potential Priced In?

    Cardiol Therapeutics shows promise with its CBD-based heart therapy, but a lack of approved drugs and a narrow pipeline raise red flags for cautious investors.

    news image

    2 months ago · newsfilecorp.com

    Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

    Designed to assess the impact of CardiolRx™ on preventing episodes of recurrent pericarditis, the first patient has been randomized by Northwestern University in Chicago. Based on a successful end-of-...

    news image

    2 months ago · newsfilecorp.com

    Cardiol Therapeutics Announces Year-End 2024 Update on Operations

    Reported positive data from the Phase II MAvERIC-Pilot study investigating the impact of CardiolRx™ administered to patients with symptomatic recurrent pericarditis; results support advancing to the P...

    Add to Watchlist